BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 10382761)

  • 1. Fcgamma receptor-mediated inhibition of human B cell activation: the role of SHP-2 phosphatase.
    Koncz G; Pecht I; Gergely J; Sármay G
    Eur J Immunol; 1999 Jun; 29(6):1980-9. PubMed ID: 10382761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
    Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
    Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
    Sármay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
    Nakamura K; Brauweiler A; Cambier JC
    J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
    Sarmay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1997 Jun; 57(1-3):159-64. PubMed ID: 9232445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
    Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
    J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA.
    Huang ZY; Hunter S; Kim MK; Indik ZK; Schreiber AD
    J Leukoc Biol; 2003 Jun; 73(6):823-9. PubMed ID: 12773515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.
    Bléry M; Kubagawa H; Chen CC; Vély F; Cooper MD; Vivier E
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2446-51. PubMed ID: 9482905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
    Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
    J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation.
    Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M
    J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
    Henshall TL; Jones KL; Wilkinson R; Jackson DE
    J Immunol; 2001 Mar; 166(5):3098-106. PubMed ID: 11207261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
    Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
    J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis.
    Famiglietti SJ; Nakamura K; Cambier JC
    Immunol Lett; 1999 May; 68(1):35-40. PubMed ID: 10397153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A.
    Shlapatska LM; Mikhalap SV; Berdova AG; Zelensky OM; Yun TJ; Nichols KE; Clark EA; Sidorenko SP
    J Immunol; 2001 May; 166(9):5480-7. PubMed ID: 11313386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chicken Ig-like receptor B2, a member of a multigene family, is mainly expressed on B lymphocytes, recruits both Src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2, and inhibits proliferation.
    Viertlboeck BC; Crooijmans RP; Groenen MA; Göbel TW
    J Immunol; 2004 Dec; 173(12):7385-93. PubMed ID: 15585863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor.
    Ulyanova T; Blasioli J; Woodford-Thomas TA; Thomas ML
    Eur J Immunol; 1999 Nov; 29(11):3440-9. PubMed ID: 10556798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.